Vitamin K2 Containing Food Product - Patent application no. 09/850,804 ("ex-Unilver") approved in USA September 17th 2012

9/18/2012 5:14 AM EST

NattoPharma ASA is pleased to announce that our patent application no.
09/850,804 ("ex-Unilvere") re. "Vitamin K2 Containing Food product" has
been approved and issued in USA by the United States Patent and Trade
Office. This will strengthen NattoPharma's IPR and commercial platform
in USA significantly. The patent will give NattoPharma a broad coverage
on the use of menaquinones (vitamin K2) in the preparation of a food
product (including dietary supplement) for maintaining, optimizing,
strengthening or promoting cardiovascular health.
"The approval of the patent represents a milestone for NattoPharma and
our partners in the US market. This will strengthen NattoPharma's global
IPR-platform and improve our competitive position in USA within the food
supplement market as well as the functional food market" says Dr. Hogne
Vik, CEO of NattoPharma.

About NattoPharma ASA
NattoPharma ASA, Norway is the exclusive international supplier of
MenaQ7, the natural vitamin K2. NattoPharma has entered into a multi
-year research and development program to substantiate and discover the
health benefits of natural vitamin K2 for applications in the exciting
marketplace for functional food and health food supplements.

For more information, please visit www.nattopharma.com

About MenaQ7
MenaQ7 provides natural vitamin K2 as a fermentation extract whereby
vitamin K2 is manufactured using bascillus subtilis natto. This process
has the capacity of producing the highly pure and bio-available form of
vitamin K2, menaquinone-7 (MK-7). MenaQ7 is the best documented,
commercially available natural vitamin K2 with guaranteed actives and
stability, clinical substantiation and international patents granted and
pending.

For more information on the health benefits of MenaQ7, please visit
www.menaq7.com

For more information, please contact:
CEO Dr. Hogne Vik
Phone: +47 975 35 3